Moreover, TGR5 activation induced the release of ileac glucagon-like peptide-1 (GLP-1; Ding et al., 2021), suggesting the potential therapeutic prospect of BAs against DN. This evidence concerns the gene GPBAR1 and liver dysplastic nodule.